Anzeige
Meldung des Tages: SILBER-TSUNAMI: $82/Unze – PRINCE SILVER EXPANDIERT BOHRPROGRAMM NACH HISTORISCHEM PREISANSTIEG

Nanalysis Scientific Aktie News

Aktie
WKN:  A2PNDW ISIN:  CA63000Y1034 US-Symbol:  NSCIF Land:  Kanada
0,118 €
+0,0225 €
+23,56%
02.01.26
Depot/Watchlist
Marktkapitalisierung *
10,69 Mio. €
Streubesitz
87,52%
KGV
-5,85
Index-Zuordnung
-

Nanalysis Scientific News

23.12.25 - PR Newswire
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche PR Newswire
08.12.25 - PR Newswire
Nanalysis Announces $2.5 Million Private Placement
Nanalysis Announces $2.5 Million Private Placement PR Newswire
24.11.25 - PR Newswire
Nanalysis Announces Third Quarter 2025 Results
Nanalysis Announces Third Quarter 2025 Results PR Newswire
18.11.25 - PR Newswire
Nanalysis Announces Third Quarter 2025 Conference Call
Nanalysis Announces Third Quarter 2025 Conference Call PR Newswire
14.11.25 - PR Newswire
Nanalysis Announces Change of Management
Nanalysis Announces Change of Management PR Newswire
07.10.25 - PR Newswire
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026 PR Newswire
03.09.25 - PR Newswire
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier PR Newswire
28.08.25 - PR Newswire
Nanalysis Announces Second Quarter 2025 Results
Nanalysis Announces Second Quarter 2025 Results PR Newswire
21.08.25 - PR Newswire
Nanalysis Announces Second Quarter 2025 Conference Call
Nanalysis Announces Second Quarter 2025 Conference Call PR Newswire
09.07.25 - PR Newswire
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European ...
28.05.25 - PR Newswire
Nanalysis Announces First Quarter 2025 Results
Nanalysis Announces First Quarter 2025 Results PR Newswire
15.05.25 - PR Newswire
Nanalysis Announces First Quarter 2025 Conference Call
Nanalysis Announces First Quarter 2025 Conference Call PR Newswire
24.04.25 - PR Newswire
Nanalysis Announces Fourth Quarter and Full Year 2024 Results
Nanalysis Announces Fourth Quarter and Full Year 2024 Results PR Newswire
17.04.25 - PR Newswire
Nanalysis Announces Fourth Quarter and Full Year 2024 Conference Call
Nanalysis Announces Fourth Quarter and Full Year 2024 Conference Call PR Newswire
18.03.25 - PR Newswire
Nanalysis Announces Release of Automation Software
Nanalysis Announces Release of Automation Software PR Newswire
05.03.25 - PR Newswire
Nanalysis Announces Next Generation 60MHz Benchtop NMR Spectrometer
Nanalysis Announces Next Generation 60MHz Benchtop NMR Spectrometer PR Newswire
27.02.25 - PR Newswire
Nanalysis Provides Fourth Quarter Preview (Unaudited)
Nanalysis Provides Fourth Quarter Preview (Unaudited) PR Newswire

Newssuche

Videos

newspaper
02.01.26 -4,63%
Technical Trading: Gold Long saisonal
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »